The number of cells that were positive for the expression of CD8 and NKp46/NCR1 was significantly increased in the anti-TNFα mAb group, indicating that immunity against the tumor was enhanced in the anti-TNFα mAb group. This evidence concerns the gene CD8A and neoplasm.